Increasing visibility with a proactive supply chain
Document
Learn how one of the world’s largest pharma organisations saves millions of dollars and thousands of tonnes of CO2 with a clean, simple, and efficient supply chain.
Logipharma report
The logistics industry now has more data on shipments than ever before. With this mountain of new data comes the responsibility for pharmaceutical companies to figure out how best to implement a proactive model so that they can act on data.
In Q4 of 2018 WBR Insights, Logipharma surveyed 100 Heads of Operations from pharma companies across Europe to find out more about the challenges they’re facing and the innovative solutions being brought to the table.
CEO Niclas Ohlsson, share TSS's view on the superiority of a proactive supply chain and the importance of placing new technology in the right context for solving the business problems of tomorrow.
Highlights:
- Recommendations on Implementing a Real-Time Monitoring Solution
- A Glimpse into the Future of Pharma Logistics
- The Evolving Digital Landscape
- Increasing Visibility
- Utilizing Real-Time Data
Complete the form below to download a copy of the report.
You may also be interested in
Visibility and automation: reducing disruption due to temperature excursions
The Covid-19 pandemic has placed a global spotlight on pharmaceuticals and the importance of temperature control. The large-scale vaccination programs being rolled out across the world depend on operators and distributors being able to monitor and manage temperatures effectively. It has also shown just how challenging this can be.
Read moreDownload Whitepaper
How GSK Pharma in UAE optimized the supply chain through automatization
Is it possible to cut costs, increase efficiency, and improve quality—all at the same time? The GSK (GlaxoSmithKline) UAE division and their main logistics company GAC (Gulf Agency Company) exceeded their expectations when they implemented temperature monitoring solutions from TSS in outbound shipments from Dubai. Additionally, they reassured the safety of what's most valuable—the patient.
Read moreDownload Whitepaper
Achieving FDA and EMA Compliance in Temperature Monitoring
Many pharmaceuticals and biological products require specific temperature conditions during manufacturing, storage, and transport to ensure their quality and safety. Failure to maintain these conditions can lead to product degradation, making them less effective or even dangerous.
Read moreDownload WhitepaperYou may also be interested in
Join Us at LogiPharma Europe 2026
From Temperature Data to Release Decisions—Rethinking Supply Chain Control
Read more
TSS Sponsors the 27th Annual Clinical Trial Supply Europe 2026 in Barcelona
TSS is proud to sponsor the 27th Annual Clinical Trial Supply Europe, taking place 24–25 February 2026 in Barcelona, Spain. The event brings together clinical supply professionals, sponsors, CROs, and solution providers to discuss how to strengthen resilience, quality, and patient safety across the clinical trial supply chain.
Read more